Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
IRX Therapeutics logo — Developing immune therapies to activate the body's natural d...

IRX Therapeutics

Developing immune therapies to activate the body's natural defense against cancer and related diseases, aiming to enhance and extend patient lives.

Founded 1994 Series Unknown Total: $127.67M Biotechnology, Health and Wellness

General Information

Company Name IRX Therapeutics
Founded Year 1994
Industries Biotechnology, Health and Wellness
Funding Stage Series Unknown
Social

Get notified when IRX Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About IRX Therapeutics

IRX Therapeutics is a biotechnology startup established in 1994 and based in New York. The company's slogan "Developing immune therapies to activate the body's natural defense against cancer and related diseases, aiming to enhance and extend patient lives" underscores its focus on creating therapies that harness a patient's immune system to combat cancer and related diseases. Their lead platform technology, IRX-2, is believed to broadly restore immune function by countering cancer-induced immune suppression. This innovative approach aims to enhance cancer treatments and improve patient outcomes. IRX Therapeutics raised a significant $33.23M in their last Venture Round investment on 29 August 2017, showcasing investor confidence in the company's mission. With a dedication to developing products that may significantly contribute to various cancer treatments and improve and extend patient lives, IRX Therapeutics is making strides in the biotechnology industry.

Taxonomy: Immune therapy, Cancer treatment, IRX-2, New York-based, Immune system activation, Cancer immunotherapy, Patient-focused, Biopharmaceutical, Immune function restoration

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 29 Aug 2017
Debt Financing •••••• - 12 May 2016
Venture Round •••••• - 17 Aug 2015
Debt Financing •••••• - 17 Mar 2014
Debt Financing •••••• - 30 May 2012

View All 8 Funding Rounds

IRX Therapeutics Alternatives & Competitors

IRX Therapeutics vs
Quentis Therapeutics
Quentis Therapeutics

Developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the f...

Grant
Biotechnology, Health Care
IRX Therapeutics vs
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. United States

Harnessing the power of the immune system to develop treatments for cancer.

Unknown
23 employees
Biotechnology
IRX Therapeutics vs
TRIO Pharmaceuticals, Inc.
TRIO Pharmaceuticals, Inc. United States

Outsmart Cancer

Seed
10 employees
Biotechnology, Health Care

FAQ About IRX Therapeutics

Developing immune therapies to activate the body's natural defense against cancer and related diseases, aiming to enhance and extend patient lives.
IRX Therapeutics was founded in 1994.
IRX Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
IRX Therapeutics has completed 8 funding rounds, raising a total of $127.67M. The latest funding stage is Series Unknown.
Top alternatives and competitors to IRX Therapeutics include Quentis Therapeutics, Tizona Therapeutics, Inc., TRIO Pharmaceuticals, Inc., IOmx, Asylia Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IRX Therapeutics and Quentis Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors IRX Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy